Chapter 6 Nathan Fairman, Jeremy M. Hirst, and Scott A. Irwin Symptoms of depression and anxiety are a common source of suffering in patients with advanced, life-threatening medical illness. In the palliative care setting, and particularly near the end of life, clinicians and caregivers may overlook the impact of these psychological symptoms, assuming that they are normal or expected experiences. However, addressing symptoms of depression and anxiety is an important therapeutic aim, for a variety of reasons. When unrecognized, or ineffectively treated, depression and anxiety can contribute to significant morbidity and mortality. High levels of psychological distress can negatively impact physical health and quality of life, complicate management of a primary illness, and contribute to significant distress in the patient, loved ones, and clinicians. Depression, for example, is a well-known risk factor for suicide, and it also independently predicts mortality in cancer [1], and it is a significant predictor of caregiver stress [2]. Similarly, anxiety symptoms in patients with advanced illness undermine quality of life and can erode patients’ trust in their physicians [3]. Fortunately, even among seriously ill patients, these symptoms can often be effectively treated. For these reasons, there is a great need for generalist competency in the identification, diagnosis, and management of depression and anxiety in palliative care patients in the acute care setting. These competencies include: This chapter is aimed at helping hospital clinicians to acquire these competencies. Several caveats warrant mention: first, for the most part, the focus of this chapter is on patients who do not have preexisting psychiatric illness (psychotic disorders, affective disorders, personality disorders, etc.). When these conditions are present, management often requires consultation with a psychiatrist, preferably with expertise/experience in psychosomatics or palliative medicine. The fourth competency—knowing when and how to consult—addresses this issue in more detail at the end of the chapter. Second, depression and anxiety both exist on continua. “Depression” can range from transient feelings of sadness to the pathological condition of unrelenting and debilitating impairments in mood and cognition that are observed in major depressive disorder (MDD). Similarly, although anxiety and worry may be part of the normal response to the stress of a serious medical problem, high levels of persistent and disabling anxiety are not an inevitable part of the illness experience for patients with an advanced medical illness [4]. MDD and anxiety disorders are psychiatric illnesses, which account for an enormous burden of suffering; yet, they are treatable. An important challenge for hospital clinicians is to be able to distinguish the normal experiences of sadness and worry from the disorders of depression and anxiety, so that these symptoms may be effectively addressed. Finally, the general approach to addressing psychiatric distress in seriously ill patients, including in the acute hospital setting, is rooted in basic palliative care principles: optimal care is provided by an interdisciplinary team, interventions need to be informed by knowledge of prognosis and goals of care, physical symptoms and other dimensions of distress need to be addressed, nonpharmacologic interventions should be optimized, and drug treatments should be provided in time-limited therapeutic trials. Symptoms of depression and anxiety are common in patients with serious medical illnesses, and prevalence estimates range widely, depending on the definitions used and populations studied. Symptoms of depression have been reported in up to 42% of patients in palliative medicine settings [5], and significant anxiety may occur in up to 70% of patients with serious medical illness [6]. In terms of psychiatric disorders, prevalence estimates have not been systematically investigated in palliative care populations, though many studies suggest that MDD and anxiety disorders—beyond just symptoms—are present at higher levels than among healthy individuals. For example, recent data indicates that 20.7% of patients with advanced cancer may meet criteria for major or minor depression, and 13.9% meet the diagnostic threshold for an anxiety disorder [6]. As in the vast majority of psychiatric illnesses, disorders of depression and anxiety are established based on a clinical diagnosis; there are no diagnostic tests to confirm a hunch, though some screening tools may be helpful. Diagnosis relies on the patient’s subjective history, collateral information from reliable sources, and careful observation by the clinician—coupled with knowledge of the distinguishing characteristics of the different conditions marked by depression and/or anxiety. Depression may manifest with obvious changes in mood (feeling sad, down, deflated, etc.) or with disinterest in enjoyable activities. In the hospital setting, such changes are frequently accompanied by disengagement during visits by loved ones or apathy and low motivation to participate in hospital treatments. Depression frequently affects patients in behavioral, cognitive, and somatic domains as well, which will be described in more detail later. The emergence of any of these changes may raise suspicion for depression. The experience of anxiety, too, may occur in several different domains—emotional, physical, behavioral, and cognitive—each associated with unique signs and symptoms. Patients frequently use words such as “concerned,” “scared,” “worried,” and “nervous” to convey the psychological experience of anxiety or fear. Attention to these keywords can aid the clinician in pinpointing the presence of anxiety [7]. In palliative care settings, anxiety is frequently described as a feeling of helplessness or fear, often generated by illness-related factors. Fear of uncontrolled symptoms, or losing independence, may even result in a desire for death. Patients with a short prognosis often worry about the dying process. They frequently voice concerns about religious beliefs, spiritual issues, existential matters, or how to achieve a good death. Several simple, clinically useful screening instruments have been shown to improve the detection of depression and anxiety, though the reliability and validity of these measures in the palliative care population have not been systematically examined [8]. With respect to depression, the Patient Health Questionnaire (PHQ-9), the Hospital Anxiety and Depression Scale (HADS), and the CES-D Boston Short Form are perhaps the most widely used, and useful, screening tools in a clinical setting for these issues. Even the simple query “Are you depressed?” has been shown to have high validity in diagnosing depression [9]. The Profile of Mood States and the Generalized Anxiety Disorder Screener (GAD–7) are commonly used, in addition to the HADS, to identify and characterize symptoms of anxiety. Perhaps the most challenging task in addressing depression and anxiety in seriously ill patients is to be able to distinguish among the many different conditions that are marked by these symptoms. For example, while depressed mood is the hallmark of MDD, this symptom may also characterize a variety of other conditions, including adjustment disorder, dysthymia, grief, and demoralization syndrome. The features that distinguish these conditions are described in detail later and summarized in Table 6.1. Since treatment approaches may differ, it can be important to distinguish one condition from another. Table 6.1 Distinguishing among Major Depressive Disorder and Its Look-Alikes Major depression is the condition against which others are compared [10]. The disorder is characterized by the presence of a major depressive episode,1 which occurs when a patient experiences either a depressed mood or anhedonia (loss of interest in pleasurable activity), nearly every day, over a period of at least 2 weeks.2 In addition, in major depression, the depressed mood or anhedonia is accompanied by a number of cognitive or somatic symptoms. Cognitive changes may include poor concentration or indecision, as well as thoughts of worthlessness, hopelessness, guilt, or death. Somatic symptoms may include changes in appetite or weight, changes in sleep, decreased energy, or changes in psychomotor activity. As with all psychiatric illnesses, significant functional impairment—major problems in relationships, at work, or in self-care—needs to be present in order for the condition to be considered pathological. Particularly in patients with serious illness and perhaps even more so in the acute care setting, differentiating normal states of sadness from major depression can be quite challenging, even for experienced clinicians. Patients with advanced illness will commonly experience episodes of intense sadness; many endure periods of anhedonia, low motivation, and even hopelessness; and it should be expected that seriously ill patients will also contemplate death. Taken individually, none of these phenomena should be assumed to indicate the presence of pathological depression. Similarly, the somatic dimensions of major depression (e.g., changes in sleep, low energy, changes in weight and appetite) frequently overlap with the physical symptoms seen in advanced medical illnesses, and so these alone are not reliable indicators of depression in this population. Instead, experts in palliative care psychiatry give greater weight to the emotional and cognitive symptoms of depression, as well as changes in mood from baseline, and the intensity and time course of symptoms [12]. Thus, feelings of worthlessness, hopelessness, guilt, or thoughts of suicide are likely to indicate major depression, whereas changes in appetite or level of energy may represent symptoms of the underlying medical illness. Similarly, true anhedonia, in which the patient is disinterested in the things that once gave pleasure (and not simply unable to engage in those activities due to physical limitations), helps to identify major depression. While major depression is the illness most clinicians have in mind when they refer to a patient as being “clinically depressed,” several other important conditions may overlap with, or may be mistaken for, MDD. Adjustment disorder occurs in the context of an identifiable stressor, in which the patient experiences marked distress (in the form of depression, anxiety, or behavioral disturbances) to a degree in excess of the intensity of the stressor. In theory, the approach to “treatment” in adjustment disorder is nonpharmacologic, aimed at bolstering coping strategies or resolving/removing the stressor. Grief, the emotional experience associated with a significant loss, is also a distinct experience from major depression, though the two conditions have in common the experience of a depressed mood [13]. Of note, in the most recent iteration of the Diagnostic and Statistic Manual of Mental Disorders (DSM), the “bereavement exception” was removed from the diagnosis of MDD, so that even in the setting of bereavement, MDD should be diagnosed (and treatment considered) if criteria are met [10]. This distinction is important because the general approach to addressing grief, in the absence of major depression, should be with supportive therapeutic interventions and not drug therapy, though medication for specific symptoms, such as insomnia, can be helpful for brief periods. Demoralization syndrome captures a suite of psychological phenomena commonly seen in patients with advanced, serious illnesses, which may overlap with major depression [11]. At the core of demoralization syndrome is a sense of subjective incompetence, arising from the loss of purpose and meaning that may result from a serious medical illness. As distinct from depression, in which anhedonia robs patients of the ability to experience pleasure, demoralization syndrome is marked by profound hopelessness, robbing patients of the ability to imagine a fulfilling future. Also, the demoralized patient retains the reactivity of mood (i.e., they can experience happiness in relation to positive events), which is frequently lost in depression. There is considerable debate, beyond the scope of this chapter, as to whether or not demoralization syndrome can be reliably distinguished from major depression. Finally, two common neurocognitive disorders, delirium and dementia, may also sometimes be mistaken for depression, particularly when marked by social withdrawal, psychomotor retardation, and abulia (diminished motivation). In both conditions, however, the predominant symptom is a significant cognitive disturbance, with an onset that is generally insidious (in the case of dementia), or acute/subacute (in the case of delirium). While cognitive deficits are seen in major depression, these tend to arise only after the emergence of changes in mood or the development of anhedonia. Anxiety symptoms may be the hallmark of a mental illness, the consequence of a physiologic problem, or the reaction to psychosocial stressors. In terms of psychiatric conditions, anxiety disorders encountered most often in palliative care settings include adjustment disorder with anxiety, generalized anxiety disorder, panic disorder, and posttraumatic stress disorder. The features that distinguish these conditions are described in Table 6.2. Other psychiatric conditions may mimic or exacerbate anxiety, and these should be distinguished from a primary anxiety disorder. In particular, depression, dementia, and delirium may each present with strong anxiety components. In the palliative care population, and perhaps even more so in the acute hospital setting, symptoms of anxiety may commonly result from physiologic derangements due to an underlying medical illness, such as advanced COPD or hyperthyroidism. What’s more, among seriously ill patients, particularly those approaching death, the social, spiritual, and existential dimensions of distress often manifest as anxiety. Table 6.3 enumerates some of these nonpsychiatric causes of anxiety. Table 6.2 Anxiety Disorders Commonly Encountered in the Palliative Care Setting
Depression and Anxiety: Assessment and Management in Hospitalized Patients with Serious Illness
6.1 INTRODUCTION
6.2 RECOGNIZING SYMPTOMS OF DEPRESSION AND ANXIETY IN SERIOUSLY ILL PATIENTS
6.2.1 Prevalence of Depression and Anxiety in Palliative Care
6.2.2 Assessment of Depression and Anxiety
6.3 DIFFERENTIATING AMONG CONDITIONS MARKED BY SYMPTOMS OF DEPRESSION AND ANXIETY
6.3.1 Differential Diagnosis: Major Depression and Its Look-Alikes
Condition
Characteristics
General Approach to Treatment
Major depressive disorder (MDD) [10]
Drug therapy
+
Psychotherapy
Persistent depressive disorder [10]
Formerly called dysthymia; conceptualized as a chronic depressive illness (whereas MDD is episodic), of mild to moderate severity, with no history of a major depressive episode
Drug therapy
+
Psychotherapy
Expanded in DSM-5 to include more serious/persistent forms in which full criteria for a major depressive episode are continuously met over a period of at least 2 years
Frequently challenging to treat, may warrant lower threshold to consult with specialist
Unspecified depressive disorder [10]
Clinically significant distress from depression, accompanied by functional impairment, but which does not meet criteria for any of the more specific depressive illnesses
Continued assessment/clarification of diagnosis
+
NOTE: this should not be used for patients experiencing normal sadness without clear functional consequences
Psychotherapy
Adjustment disorder
with depressed mood [10]
Emotional/behavioral symptoms that develop within 3 months of an identifiable stressor
Supportive counseling aimed at bolstering coping skills
Symptoms are disproportionate to the severity or intensity of the stressor
Problem solving aimed at resolving/removing stressor
May occur with features of depression, anxiety, behavior, or any combination
NOTE: if criteria are met for MDD, MDD should be diagnosed and not adjustment disorder
Grief [10]
In grief, the predominant emotional state is characterized by emptiness and loss; in MDD, it is depressed mood and/or inability to experience pleasure
Supportive counseling/psychotherapy
In grief, dysphoria often occurs in waves, generally triggered by thoughts/memories of the deceased; in MDD, dysphoria is unrelenting, and cognitions center on worthlessness/hopelessness
In grief, the mood state is reactive (i.e., individuals can have periods of happiness, laughter, etc. in relation to pleasant or humorous experiences); in MDD, the mood state can be pervasive or intractable
In grief, self-esteem may be preserved, and if feelings of guilt are present, they are usually constrained to the relationship with the deceased
In grief, thoughts of death often concern “joining” the deceased; in MDD, they are aimed at ending one’s own life and rooted in feelings of hopelessness and worthlessness
NOTE: bereavement is no longer an exclusion criteria for MDD. Even in the setting of bereavement, if criteria are met for MDD, MDD should be diagnosed and appropriate treatment initiated
Demoralization [11]
Marked by subjective incompetence (sense of failure), hopelessness, and despair
Often, reactivity of mood is preserved
Insufficient evidence for demoralization as a separate diagnostic category
6.3.2 Differential Diagnosis: Anxiety Disorders and Anxiety Symptoms
Condition
Characteristics
General Approach to Treatment
Adjustment disorder with anxiety [10]
Emotional/behavioral symptoms that develop within 3 months of an identifiable stressor
Supportive counseling aimed at bolstering coping skills
Symptoms are disproportionate to the severity or intensity of the stressor
Problem solving aimed at resolving/removing stressor
May occur with features of depression, anxiety, behavior, or any combination
Symptoms do not meet criteria for any particular anxiety disorder
Symptom-focused, time-limited drug treatments
Generalized anxiety disorder [10]
A state of excessive and uncontrollable anxiety or worry, lasting at least 6 months and impacting day-to-day activities
Drug therapy
+
Psychotherapy
People suffering with generalized anxiety are often described as worriers by their friends and families
Panic attack/panic disorder [10]
Sudden onset of intense discomfort apprehension, fearfulness, terror, or a feeling of impending doom, usually occurring with symptoms such as shortness of breath, palpitations, chest discomfort, a sense of choking, and fear of “going crazy” or losing control, often in unexpected situations
Psychotherapy (cognitive behavioral)
+
Drug therapy
Panic attacks are discrete, usually lasting 15–20 min
Panic disorder is marked by recurrent panic attacks occur, accompanied by worry about future attacks, with significant impairment in psychosocial functioning
Posttraumatic stress disorder [10]
Reexperiencing of a traumatic event, with symptoms of increased arousal, nightmares, intrusive memories, hypervigilance, and avoidance of reminders of the event
Drug therapy
+
Psychotherapy